Your session is about to expire
← Back to Search
Cementless Hip Replacement
Trident II Tritanium Acetabular Shell for Revision in Hip Revision Surgery
N/A
Waitlist Available
Research Sponsored by Stryker Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 3-6 months, 1 year and 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the long-term outcomes of two types of hip replacement surgeries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks, 3-6 months, 1 year and 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 3-6 months, 1 year and 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Cases Free From Trident II Acetabular Shell Revision
Secondary study objectives
Radiographic Stability
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Trident II Tritanium Acetabular Shell for RevisionExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Stryker OrthopaedicsLead Sponsor
78 Previous Clinical Trials
20,430 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Trident II Tritanium Acetabular Shell for Revision
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.